Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms.
about
Microdosing and drug development: past, present and futureDrug-drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer.The application of human phase 0 microdosing trials: A systematic review and perspectives.Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approachesHuman microdose evaluation of the novel EP1 receptor antagonist GSK269984A.
P2860
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Case studies addressing human ...... tive first in human paradigms.
@en
Case studies addressing human ...... tive first in human paradigms.
@nl
type
label
Case studies addressing human ...... tive first in human paradigms.
@en
Case studies addressing human ...... tive first in human paradigms.
@nl
prefLabel
Case studies addressing human ...... tive first in human paradigms.
@en
Case studies addressing human ...... tive first in human paradigms.
@nl
P2093
P2860
P1433
P1476
Case studies addressing human ...... tive first in human paradigms.
@en
P2093
Alex Phipps
Anthony Harrison
Gill Allan
Iain Gardner
Ian Gurrell
Jonathan Duckworth
Kevin Beaumont
Louise Taylor
Lynn Purkins
Marie Simpson
P2860
P356
10.3109/00498254.2011.622418
P407
P577
2011-10-12T00:00:00Z